Mohs Micrographic Surgery and Reconstruction in the Optum Insurance Claims Database

Withdrawn

• Conditions: Interpolated Flap Repair; Mohs Micrographic Surgery; Skin Cancer

• Registration Number: NCT04117373
• Lead Sponsor: University of Pennsylvania

Brief Summary

Mohs micrographic surgery (MMS) followed by skin reconstruction has been widely accepted for treatment of many skin cancers. To further characterize the trends in MMS and reconstruction for skin cancer, a retrospective analysis will be performed using the Optum© Clinformatics® DataMart de-identified commercial claims database from 2001-2016. The findings may provide critical data for future prospective studies in skin cancer treatments.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-01
• Study First Submitted: 2019-10-03
• Study First Submitted QC: 2019-10-04
• Study First Posted: 2019-10-07
• Primary Completion: 2019-12-31
• Study Completion: 2019-12-31
• Status Verified: 2020-03
• Last Update Submitted: 2020-03-04
• Last Update Posted: 2020-03-06

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary cost	Claims from 2001-2016 will be analyzed	How does interpolation flap procedure cost differ across settings

Secondary Outcome Measures

Name	Time	Method
Predictors of inpatient vs. outpatient procedure	Claims from 2001-2016 will be analzyed	How does medical specialty or geographical location predict where the procedure is performed

Trial Locations

Locations (1)

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States